LadRx Corporation (LADX)

Market Cap	25.25K -97.3%
Revenue (ttm)	n/a
Net Income	-2.50M
EPS	-5.04
Shares Out	495.09K
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,100
Average Volume	1,662
Open	0.0500
Previous Close	0.0100
Day's Range	0.0500 - 0.0500
52-Week Range	0.0001 - 2.2000
Beta	0.49
RSI	41.63
Earnings Date	Mar 18, 2026

About LadRx

LadRx Corporation, a biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors in the United States. The company offers linker activated drug releases (LADR) technology, a platform consists of an organic backbone that is attached to a chemotoxic agent that targets and delivers the chemotoxic agent to the tumor environment and release within the tumor. Its lead candidates comprising LADRs 7, 8, 9, and 10 with novel derivatives of the auristatin and maytansinoid drug targeting tumors; and aldoxorubi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1985
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: LADX